Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank95
3Y CAGR+78.7%
5Y CAGR+39.9%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+78.7%/yr
Quarterly compound
5Y CAGR
+39.9%/yr
Recent acceleration
Percentile
P95
Near historical high
vs 5Y Ago
5.4x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 27.77% |
| Q3 2025 | -8.23% |
| Q2 2025 | -12.69% |
| Q1 2025 | 0.93% |
| Q4 2024 | 21.29% |
| Q3 2024 | -11.16% |
| Q2 2024 | -0.00% |
| Q1 2024 | -2.71% |
| Q4 2023 | 20.06% |
| Q3 2023 | -9.21% |
| Q2 2023 | 5.26% |
| Q1 2023 | 33.28% |
| Q4 2022 | 4.86% |
| Q3 2022 | -6.35% |
| Q2 2022 | -3.22% |
| Q1 2022 | -12.82% |
| Q4 2021 | 36.31% |
| Q3 2021 | -3.62% |
| Q2 2021 | -4.57% |
| Q1 2021 | 2.03% |
| Q4 2020 | 5.18% |
| Q3 2020 | 8.44% |
| Q2 2020 | -4.39% |
| Q1 2020 | -12.65% |
| Q4 2019 | 18.78% |
| Q3 2019 | -7.92% |
| Q2 2019 | 8.82% |
| Q1 2019 | -10.27% |
| Q4 2018 | 17.99% |
| Q3 2018 | -4.58% |
| Q2 2018 | -7.61% |
| Q1 2018 | -3.52% |
| Q4 2017 | 23.27% |
| Q3 2017 | -14.07% |
| Q2 2017 | 3.06% |
| Q1 2017 | -6.69% |
| Q4 2016 | 19.60% |
| Q3 2016 | -1.44% |
| Q2 2016 | -6.37% |
| Q1 2016 | -0.66% |